Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 8, 2019
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
Thu, November 7, 2019
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
Andrew Mok Maintained (AMED) at Hold with Increased Target to $154 on, Nov 7th, 2019
Andrew Mok of UBS, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $144 to $154 on, Nov 7th, 2019.
Andrew has made no other calls on AMED in the last 4 months.
There are 4 other peers that have a rating on AMED. Out of the 4 peers that are also analyzing AMED, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Initiated at Hold and Held Target at $145 on, Tuesday, October 22nd, 2019
These are the ratings of the 3 analyists that currently disagree with Andrew
- Whit Mayo of "Baird" Upgraded from Hold to Buy on, Friday, November 1st, 2019
- Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $155 on, Tuesday, September 17th, 2019
- John Ransom of "Raymond James" Maintained at Buy with Increased Target to $144 on, Monday, July 15th, 2019
